(Q37595296)
Statements
1 reference
Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma (English)
1 reference
David B T La Vine
1 reference
Teresa A Coleman
1 reference
Carol H Davis
1 reference
Christine E Carbonell
1 reference
Wendy B Davis
1 reference
1 June 2010
1 reference
1 reference
33
1 reference
3
1 reference
217-220
1 reference
Identifiers
1 reference
1 reference